|  Research Summary  |  Publications  |

Research Summary

1. A Phase 2, Open-Label , Parallel Group, Multi-Center Study to Assess the Safety and Efficacy of Alefacept in De Novo Kidney Transplant Recipients. (Role: Co-Investigator)

2. CTOT-02/CCTPT-02 B-Cell Depletion by Anti-CD20 (Rituximab) in Renal Allograft Recipients Who Develop de novo Anti-HLA Alloantibodies will Result in Inhibition of Alloantibody Production and Attenuation of Chronic Humoral Rejection.  (Role: Co-Investigator)

3. Characterization of Immunological Profile of Renal Transplant Patients Undergoing Induction Treatment With Thymoglobulin Vs. IL-2 Receptor Antagonist Basiliximab. (Role: Co-Investigator)

4. The Development of Immune Monitoring Assays in Renal Transplant Recipients. (Role: Co-Investigator)

Back to the top

Publications

To access Dr. Sayeed Malek's publications, please click here.

Back to the top

Sayeed Malek
MD

Clinical Profile & Contact Information

Research Interests

Renal Transplant